Progen’s Experimental Drug Fails in Lung Cancer Study
September 24th, 2007
Progen Pharmaceuticals Ltd., the Australian developer of oncology medicines, said its leading product candidate failed a study in patients with advanced lung cancer.
LUNG CANCER SURPASSED BREAST
CANCER AS THE #1 KILLER OF
WOMEN IN 1987.